Sanofi
VS
Scribe Therapeutics

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

S
Sanofi

Sanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines across specialty care, immunology, oncology, and rare diseases.

2 Pulse stories
ST
Scribe Therapeutics

Clinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.

5 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
1973
Founded
2018
Paris, France
HQ
Alameda, California
Public (SNY)
Status
Public (SCTX)
Sanofi investors
No investors on record.
Scribe Therapeutics investors
No investors on record.

Data from Value Add Pulse coverage and company research — see the full threads for Sanofi and Scribe Therapeutics.